|Bid||4.3500 x 800|
|Ask||4.3700 x 800|
|Day's range||4.2600 - 4.6800|
|52-week range||2.7500 - 22.5500|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||16.37|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Focusing on a stock's short-term price movements is a losing game, and it's often the case that big dips or jumps have nothing to do with a company's chances of future success. For example, over the last month, shares of Cue Health (NASDAQ: HLTH) have fallen by nearly 38% despite reporting strong earnings on March 29.
Cue Health (HLTH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
New high-tech Covid-19 tests promise better and earlier detection of the virus—similar to a PCR test. WSJ’s Joanna Stern (and her mannequin clone) tried out the Detect Covid-19 Test and Cue Health Monitoring System to see how they compare with rapid antigen tests. Photo illustration: Ryan Trefes/ WSJ